Decision-making performance of large language models vs. human physicians in challenging lung cancer cases: A real-world case-based study[J]. Intelligent Oncology, 2026, 2(1): 100039.
DOI:
Decision-making performance of large language models vs. human physicians in challenging lung cancer cases: A real-world case-based study[J]. Intelligent Oncology, 2026, 2(1): 100039.DOI: 10.1016/j.intonc.2026.100039.
Decision-making performance of large language models vs. human physicians in challenging lung cancer cases: A real-world case-based study
BackgroundDespite the promise shown by large language models (LLMs) for standardized tasks
their multidimensional performance in real-world oncology decision-making remains unevaluated. This study aims to introduce a framework for evaluating LLMs and physician decisions in challenging lung cancer cases.MethodsWe curated 50 challenging lung cancer cases (25 local and 25 published) classified as complex
rare
or refractory. Blinded three-dimensional
five-point Likert evaluations (1–5 for comprehensiveness
specificity
and readability) compared standalone LLMs (DeepSeek R1
Claude 3.5
Gemini 1.5
and GPT-4o)
physicians by experience level (junior
intermediate
and senior)
and AI-assisted juniors; intergroup differences and augmentation effects were analyzed statistically.ResultsOf 50 challenging cases (18 complex
17 rare
and 15 refractory) rated by three experts
DeepSeek R1 achieved scores of 3.95 ± 0.33
3.71 ± 0.53
and 4.26 ± 0.18 for comprehensiveness
specificity
and readability
respectively
positioning it between intermediate (3.68
3.68
3.75) and senior (4.50
4.64
4.53) physicians. GPT-4o and Claude 3.5 reached intermediate physician–level comprehensiveness (3.76 ± 0.39
3.60 ± 0.39) but junior-to-intermediate physician–level specificity (3.39 ± 0.39
3.39 ± 0.49). All LLMs scored higher on rare cases than intermediate physicians but fell below junior physicians in refractory-case specificity. AI-assisted junior physicians showed marked gains in rare cases
with comprehensiveness rising from 2.32 to 4.29 (84.8%)
specificity from 2.24 to 4.26 (90.8%)
and readability from 2.76 to 4.59 (66.0%)
while specificity declined by 3.2% (3.17 to 3.07) in refractory cases. Error analysis showed complementary strengths
with physicians demonstrating reasoning stability and LLMs excelling in knowledge updating and risk management.ConclusionsLLMs performed variably in clinical decision-making tasks depending on case type
performing better in rare cases and worse in refractory cases requiring longitudinal reasoning. Complementary strengths between LLMs and physicians support case- and task-tailored human–AI collaboration.
Abstract
BackgroundDespite the promise shown by large language models (LLMs) for standardized tasks
their multidimensional performance in real-world oncology decision-making remains unevaluated. This study aims to introduce a framework for evaluating LLMs and physician decisions in challenging lung cancer cases.MethodsWe curated 50 challenging lung cancer cases (25 local and 25 published) classified as complex
rare
or refractory. Blinded three-dimensional
five-point Likert evaluations (1–5 for comprehensiveness
specificity
and readability) compared standalone LLMs (DeepSeek R1
Claude 3.5
Gemini 1.5
and GPT-4o)
physicians by experience level (junior
intermediate
and senior)
and AI-assisted juniors; intergroup differences and augmentation effects were analyzed statistically.ResultsOf 50 challenging cases (18 complex
17 rare
and 15 refractory) rated by three experts
DeepSeek R1 achieved scores of 3.95 ± 0.33
3.71 ± 0.53
and 4.26 ± 0.18 for comprehensiveness
specificity
and readability
respectively
positioning it between intermediate (3.68
3.68
3.75) and senior (4.50
4.64
4.53) physicians. GPT-4o and Claude 3.5 reached intermediate physician–level comprehensiveness (3.76 ± 0.39
3.60 ± 0.39) but junior-to-intermediate physician–level specificity (3.39 ± 0.39
3.39 ± 0.49). All LLMs scored higher on rare cases than intermediate physicians but fell below junior physicians in refractory-case specificity. AI-assisted junior physicians showed marked gains in rare cases
with comprehensiveness rising from 2.32 to 4.29 (84.8%)
specificity from 2.24 to 4.26 (90.8%)
and readability from 2.76 to 4.59 (66.0%)
while specificity declined by 3.2% (3.17 to 3.07) in refractory cases. Error analysis showed complementary strengths
with physicians demonstrating reasoning stability and LLMs excelling in knowledge updating and risk management.ConclusionsLLMs performed variably in clinical decision-making tasks depending on case type
performing better in rare cases and worse in refractory cases requiring longitudinal reasoning. Complementary strengths between LLMs and physicians support case- and task-tailored human–AI collaboration.